scholarly article | Q13442814 |
P356 | DOI | 10.1378/CHEST.125.5.1952 |
P698 | PubMed publication ID | 15136414 |
P50 | author | Catherine M Greene | Q56915426 |
P2093 | author name string | Noel G McElvaney | |
Mark L Brantly | |||
Clifford C Taggart | |||
Matthew W Lawless | |||
Shane J O'Neill | |||
Alan T Mulgrew | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1952-1957 | |
P577 | publication date | 2004-05-01 | |
P1433 | published in | Chest | Q5093377 |
P1476 | title | Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant | |
P478 | volume | 125 |
Q37144496 | A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema |
Q38797163 | Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies |
Q38092905 | Airway disease in alpha-1 antitrypsin deficiency |
Q37056312 | Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations. |
Q37986292 | Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent |
Q35063726 | Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes |
Q36846798 | Alpha-1-antitrypsin deficiency: current concepts |
Q38581002 | Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis |
Q34428996 | Alpha1-antitrypsin deficiency |
Q36925199 | Alpha1-antitrypsin deficiency: a clinical-genetic overview |
Q38937853 | An ECLIPSE View of Alpha-1 Antitrypsin Deficiency |
Q41112254 | Cigarette Smoke and DNA Cleavage Promote Lung Inflammation and Emphysema |
Q90515735 | Clarifying the Risk of Lung Disease in SZ α1-antitrypsin Deficiency |
Q57778139 | Deficiência de alfa-1 antitripsina: diagnóstico e tratamento |
Q36032652 | Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease. |
Q36444154 | Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy. |
Q42176276 | Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency |
Q24630805 | Genes and chronic obstructive pulmonary disease |
Q57980231 | Identification of a 4-mer Peptide Inhibitor that Effectively Blocks the Polymerization of Pathogenic Z α1-Antitrypsin |
Q39085645 | Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z α1-antitrypsin |
Q33880491 | Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy. |
Q42686567 | Inflammatory markers in chronic obstructive pulmonary disease patients with different α1 antitrypsin genotypes |
Q37804626 | Lung disease associated with alpha1-antitrypsin deficiency |
Q37326944 | Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium |
Q37466723 | New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy |
Q35665638 | Novel aspects of pathogenesis and regeneration mechanisms in COPD |
Q51536039 | Oxidation of Z α1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema. |
Q37395759 | Oxidative damage to nucleic acids in severe emphysema |
Q37343918 | Oxidized {alpha}1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema |
Q43180243 | Parker B. Francis lectureship. Antitrypsin deficiency, the serpinopathies, and chronic obstructive pulmonary disease |
Q37203729 | Polymers and inflammation: disease mechanisms of the serpinopathies |
Q35755014 | Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo |
Q35098361 | Prevalence of α-1-antitrypsin gene mutations in Saudi Arabia. |
Q37447482 | Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery |
Q34928474 | Protein misfolding and the serpinopathies |
Q42790541 | Proteostasis: a new therapeutic paradigm for pulmonary disease |
Q23911017 | Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis. Alpha-1 protocol |
Q38111790 | Recent advances in α-1-antitrypsin deficiency-related lung disease |
Q28387428 | SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort |
Q37303247 | Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency. |
Q39899143 | Small-molecule peptides inhibit Z alpha1-antitrypsin polymerization |
Q55259593 | The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions. |
Q38604663 | The Natural History of Lung Function in Severe Deficiency of Alpha-1 Antitrypsin Following Orthotopic Liver Transplantation: A Case Report |
Q51465407 | The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency. |
Q55011363 | The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals. |
Q35162540 | The prevalence of alpha-1 antitrypsin deficiency in Ireland |
Q37894093 | The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency |
Q36378692 | The selective advantage of alpha1-antitrypsin deficiency |
Q38092851 | Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency |
Q61044333 | Update on α-antitrypsin deficiency |
Q35233352 | Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis |
Q33901639 | Z α1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease |
Q35607245 | alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis |
Q37474870 | alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies |
Q37855954 | α(1)-antitrypsin deficiency and inflammation |
Search more.